In ANCA-associated vasculitis in remission, tailored vs fixed-schedule rituximab did not differ for relapse at 28 months.

Journal Article

Full Text

Duke Authors

Cited Authors

  • St Clair, EW

Published Date

  • September 18, 2018

Published In

Volume / Issue

  • 169 / 6

Start / End Page

  • JC33 -

PubMed ID

  • 30242406

Pubmed Central ID

  • 30242406

Electronic International Standard Serial Number (EISSN)

  • 1539-3704

Digital Object Identifier (DOI)

  • 10.7326/ACPJC-2018-169-6-033

Language

  • eng

Conference Location

  • United States